Ming‐Chao Tsai

2.0k total citations
104 papers, 1.4k citations indexed

About

Ming‐Chao Tsai is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Ming‐Chao Tsai has authored 104 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hepatology, 74 papers in Epidemiology and 18 papers in Cancer Research. Recurrent topics in Ming‐Chao Tsai's work include Liver Disease Diagnosis and Treatment (65 papers), Hepatitis C virus research (45 papers) and Hepatitis B Virus Studies (39 papers). Ming‐Chao Tsai is often cited by papers focused on Liver Disease Diagnosis and Treatment (65 papers), Hepatitis C virus research (45 papers) and Hepatitis B Virus Studies (39 papers). Ming‐Chao Tsai collaborates with scholars based in Taiwan, United States and Italy. Ming‐Chao Tsai's co-authors include Tsung‐Hui Hu, Chien‐Hung Chen, Yi‐Hao Yen, Kuo‐Chin Chang, Chao‐Hung Hung, Sheng‐Nan Lu, Po‐Lin Tseng, Jing‐Houng Wang, Ming‐Tsung Lin and Yuan‐Hung Kuo and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Ming‐Chao Tsai

101 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming‐Chao Tsai Taiwan	21	948	896	245	195	144	104	1.4k
Ming‐Ling Chang Taiwan	22	1.2k 1.3×	1.1k 1.3×	302 1.2×	157 0.8×	205 1.4×	121	1.9k
Carlo Saitta Italy	19	684 0.7×	582 0.6×	179 0.7×	110 0.6×	151 1.0×	70	1.4k
S. Nishiguchi Japan	18	1.3k 1.3×	1.4k 1.5×	292 1.2×	158 0.8×	156 1.1×	35	1.9k
Xiaogang Xiang China	21	739 0.8×	507 0.6×	261 1.1×	127 0.7×	131 0.9×	61	1.3k
Melisa Dirchwolf Argentina	14	512 0.5×	543 0.6×	221 0.9×	169 0.9×	168 1.2×	27	987
Goki Suda Japan	19	433 0.5×	475 0.5×	332 1.4×	162 0.8×	111 0.8×	71	1.0k
Motohiko Tanaka Japan	15	1.2k 1.2×	1.4k 1.5×	197 0.8×	96 0.5×	136 0.9×	49	1.8k
Fusao Ikeda Japan	26	1.3k 1.4×	1.5k 1.6×	320 1.3×	142 0.7×	268 1.9×	115	2.3k
Wei‐Yu Kao Taiwan	19	795 0.8×	854 1.0×	93 0.4×	121 0.6×	285 2.0×	68	1.2k
Nobuyuki Toshikuni Japan	20	813 0.9×	757 0.8×	261 1.1×	112 0.6×	275 1.9×	63	1.5k

Countries citing papers authored by Ming‐Chao Tsai

Since Specialization

Citations

This map shows the geographic impact of Ming‐Chao Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chao Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chao Tsai more than expected).

Fields of papers citing papers by Ming‐Chao Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Chao Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chao Tsai. The network helps show where Ming‐Chao Tsai may publish in the future.

Co-authorship network of co-authors of Ming‐Chao Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Chao Tsai. A scholar is included among the top collaborators of Ming‐Chao Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Chao Tsai. Ming‐Chao Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Joo Young, et al.. (2024). IMPACT OF HIGH-DOSE INHALED CORTICOSTEROIDS: A CASE OF AVASCULAR NECROSIS. Annals of Allergy Asthma & Immunology. 133(6). S117–S117.

Lin, Yen‐Po, Yu‐Chieh Tsai, Pao‐Yuan Huang, et al.. (2024). Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individuals. Advances in digestive medicine. 11(3). 129–139. 1 indexed citations

Tai, Wei‐Chen, Chih‐Ming Liang, Cheng‐Kun Wu, et al.. (2024). Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease. Journal of Microbiology Immunology and Infection. 58(1). 62–69. 37 indexed citations

Yen, Yi‐Hao, Kwong‐Ming Kee, Weifeng Li, et al.. (2023). Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients. Cancers. 15(4). 1222–1222. 6 indexed citations

Hsiao, Ya‐Wen, Jing‐Houng Wang, Yen‐Hao Chen, et al.. (2023). Well‐controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib. The Kaohsiung Journal of Medical Sciences. 39(12). 1233–1242. 1 indexed citations

Yao, Chih‐Chien, Jing‐Houng Wang, Chien‐Hung Chen, et al.. (2023). Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Diagnostics. 13(4). 696–696. 2 indexed citations

Wang, Peiming, Chee‐Chien Yong, Yueh‐Wei Liu, et al.. (2022). The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma. Medicina. 58(2). 259–259. 5 indexed citations

Huang, Shih‐Chung, Chen‐Lin Chang, Wen‐Chin Lee, et al.. (2022). DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes. 13(4). 629–629. 2 indexed citations

Lin, Yen‐Po, Chih‐Chi Wang, Chih‐Che Lin, et al.. (2021). Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection. Journal of Personalized Medicine. 11(8). 684–684. 18 indexed citations

10.

Tsai, Ming‐Chao, Chih‐Che Lin, Yueh‐Wei Liu, et al.. (2021). The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy. Medicina. 57(6). 574–574. 2 indexed citations

11.

Chen, Kuang‐Den, Chien‐Ning Hsu, Yi‐Ju Wu, et al.. (2021). The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma. Diagnostics. 11(2). 209–209. 1 indexed citations

12.

Wang, Peiming, Chih‐Chi Wang, Chee‐Chien Yong, et al.. (2021). Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study. Journal of Personalized Medicine. 11(12). 1261–1261. 5 indexed citations

13.

Tsai, Ming‐Chao, Yu-Yin Liu, Chih‐Che Lin, et al.. (2020). Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. Nutrients. 12(3). 820–820. 70 indexed citations

14.

Tsai, Ming‐Chao, Chun‐Yen Lin, Chien‐Hung Chen, et al.. (2020). Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment. PLoS ONE. 15(4). e0231102–e0231102. 11 indexed citations

15.

Yen, Yi‐Hao, Pao‐Yuan Huang, Chih‐Che Lin, et al.. (2019). The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection. Gastroenterology Research and Practice. 2019. 1–9. 3 indexed citations

16.

Huang, Pao‐Yuan, Chih‐Chi Wang, Chih‐Che Lin, et al.. (2019). Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy. Journal of Clinical Medicine. 8(10). 1676–1676. 24 indexed citations

17.

Yen, Yi‐Hao, Fang‐Ying Kuo, Kwong‐Ming Kee, et al.. (2018). Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. Digestive and Liver Disease. 51(1). 142–148. 2 indexed citations

18.

Yen, Yi‐Hao, Ming‐Tsung Lin, Fang‐Ying Kuo, et al.. (2017). The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients. Liver International. 38(6). 1064–1073. 14 indexed citations

19.

Hu, Tsung‐Hui, Kuo‐Chin Chang, Po‐Lin Tseng, et al.. (2017). Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy. Medicine. 96(46). e8696–e8696. 9 indexed citations

20.

Goossens, Nicolas, Guo J, Ming‐Chao Tsai, et al.. (2015). A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection. Gut. 65(10). 1754–1764. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact